Gilead Sciences Gets a Hold Rating from Credit Suisse

The institutional investor held 220,613 shares of the health care company at the end of 2017Q4, valued at $15.81M, up from 25,600 at the end of the previous reported quarter. Brave Asset Management Inc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $97.39B market cap company. (NASDAQ:GILD). Baldwin Mgmt Limited Liability Com has invested 0.23% in Gilead Sciences, Inc. Following the sale, the director now owns 58,452 shares in the company, valued at $4,416,633.12. MGIC Investment Corporation (NYSE:MTG) has risen 30.58% since April 17, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Aspiriant Llc decreased its stake in Comcast Corp New (CMCSA) by 85.89% based on its latest 2017Q4 regulatory filing with the SEC. The institutional investor held 9,807 shares of the television services company at the end of 2017Q4, valued at $393,000, down from 69,499 at the end of the previous reported quarter. Long Pond Capital Lp who had been investing in Taubman Ctrs Inc for a number of months, seems to be bullish on the $4.94 billion market cap company. Meanwhile, real estate snagged the smallest gains, up 0.50 per cent.US stocks appeared to sustain last week's strength as fears about an escalating conflict with Russian Federation and Iran eased following the missile strikes conducted by the US, UK and France on Syria on Saturday morning. (NASDAQ:DRNA) for 168,400 shares. It has underperformed by 20.84% the S&P500. 5,000 Gilead Sciences, Inc. GILD's profit will be $2.07 billion for 11.90 P/E if the $1.59 EPS becomes a reality. Ww Asset Mngmt Inc holds 0.28% in Gilead Sciences, Inc.

Among 5 analysts covering Insperity Inc (NYSE:NSP), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 20% are positive. Aon Corporation had 52 analyst reports since August 3, 2015 according to SRatingsIntel. The firm earned "Hold" rating on Tuesday, January 2 by BMO Capital Markets. (NYSE:OGE) on Friday, August 14 with "Hold" rating. The company was maintained on Tuesday, October 3 by Jefferies. The stock has "Market Perform" rating by Wells Fargo on Friday, December 4. The firm has "Buy" rating by SunTrust given on Thursday, October 26. The stock has "Outperform" rating by Credit Suisse on Wednesday, September 14. (NYSE:V) has "Overweight" rating given on Wednesday, October 18 by Barclays Capital. Citigroup has "Buy" rating and $166 target.

Investors sentiment increased to 1.28 in 2017 Q4. Its up 0.05, from 1 in 2017Q3. It also increased its holding in J2 Global Inc (NASDAQ:JCOM) by 33,422 shares in the quarter, for a total of 99,453 shares, and has risen its stake in Ishares Tr (EEM). 123 funds opened positions while 603 raised stakes. Indexiq Ltd Liability Corp reported 0.06% stake. Headinvest Ltd Liability invested in 53,455 shares. Ipswich Mngmt holds 8,566 shares or 0.26% of its portfolio. Pinnacle has invested 1.6% in Exxon Mobil Corporation (NYSE:XOM). Macquarie Group Ltd. increased its stake in shares of Gilead Sciences by 26.6% in the 3rd quarter. Sunbelt Securities accumulated 18,753 shares. Bradley Foster & Sargent Inc Ct holds 0.15% or 57,328 shares in its portfolio. (NASDAQ:GILD). Cincinnati Comm accumulated 76,000 shares. Greenleaf Trust stated it has 5,277 shares or 0.01% of all its holdings. About 646,229 shares traded. 1St Source Fincl Bank holds 0.07% or 21,265 shares.

Since January 2, 2018, it had 0 insider buys, and 17 insider sales for $39.51 million activity. (NASDAQ:GILD) was sold by WILSON GAYLE E on Friday, February 9. The ratio is a comparison of the firm's net asset value per share to it's current price. Shares for $996,628 were sold by Chapman Neil A.

American Capital Management Inc, which manages about $1.67 billion US Long portfolio, upped its stake in Balchem (NASDAQ:BCPC) by 4,720 shares to 22,280 shares, valued at $1.80M in 2017Q4, according to the filing.

Читайте также: India protests as Pak stops Sikh pilgrims from meeting envoys

Gilead Sciences (NASDAQ:GILD) last posted its earnings results on Tuesday, February 7th. Therefore 70% are positive. (NYSE:MRK) on Monday, July 17 with "Hold" rating. $2.37M worth of Gilead Sciences, Inc. (NASDAQ:GILD) has "Outperform" rating given on Wednesday, July 29 by Oppenheimer. The stock of Taubman Centers, Inc. The firm has "Buy" rating given on Monday, August 17 by Vetr.

Gilead Sciences, Inc, a biopharmaceutical company, discovers, develops, and commercializes therapeutics in the areas of unmet medical needs in the United States, Europe, and internationally. (NASDAQ:GILD)'s stock has been -7.02% and 13.15% for the last 12 months. The rating was downgraded by Morgan Stanley to "Equal-Weight" on Friday, October 2. The company now has a consensus rating of "Buy" and an average target price of $88.61. Bank of America boosted their price objective on Gilead Sciences from $82.00 to $87.00 and gave the stock a "neutral" rating in a research report on Wednesday, February 7th. National Bank Hapoalim Bm stated it has 0.33% in Gilead Sciences, Inc. The firm has "Outperform" rating by RBC Capital Markets given on Wednesday, February 3.

Investors sentiment increased to 7.58 in 2017 Q4. That's change of 0.23, from 2017Q3's 1.03. It increased, as 30 investors sold TCO shares while 63 reduced holdings. 122 funds opened positions while 455 raised stakes. Investors holded 957.62 million in 2017Q3 but now own 972.68 million shares or 1.57% more.

Director, Martin John C, sold 50,000 common shares of Gilead Sciences, Inc. Credit Suisse maintained the shares of GILD in report on Wednesday, January 3 with "Hold" rating. Hap Trading Lc has 42,943 shares for 0.13% of their portfolio. Huntington Bancshares has invested 0.24% in Gilead Sciences, Inc. Forward P/E of Gilead Sciences, Inc.is standing at 11.25. (NASDAQ:GILD). Fdx Advsr holds 45,306 shares or 0.09% of its portfolio. Bar Harbor Tru holds 5,014 shares. Looking at the big picture from the data above, the average analyst rating for Gilead Sciences, Inc.is 2.20. Holt Capital Ltd Dba Holt Capital L P, Texas-based fund reported 7,580 shares. Clear Harbor Asset Mngmt Ltd holds 0.15% of its portfolio in Gilead Sciences, Inc. Moreover, E&G Advisors Ltd Partnership has 0.09% invested in QUALCOMM Incorporated (NASDAQ:QCOM) for 3,361 shares. Franklin Resource Incorporated holds 13.85 million shares or 0.48% of its portfolio. Maxim Group upgraded Gilead Sciences, Inc. Following the completion of the sale, the chief financial officer now owns 23,749 shares of the company's stock, valued at approximately $1,907,282.19.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

При любом использовании материалов сайта и дочерних проектов, гиперссылка на обязательна.
«» 2007 - 2018 Copyright.
Автоматизированное извлечение информации сайта запрещено.

Код для вставки в блог
The institutional investor held 220,613 shares of the health care company at the end of 2017Q4, valued at $15.81M, up from 25,600 at the end of the previous reported quarter. Brave Asset Management In...
http:///2018/04/gilead-sciences-gets-a-hold-rating-from-credit-suisse/

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.